Carmela Ciccarelli - Search Results

Year	Number of Results
2002	1
2005	2
2006	2
2008	1
2009	1
2011	2
2012	1
2013	2
2014	3
2016	2
2018	1
2019	2
2020	1
2022	1
2024	0

1

Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation.

Marampon F, Ciccarelli C, Zani BM. Marampon F, et al. Among authors: ciccarelli c. Int J Mol Sci. 2019 May 23;20(10):2530. doi: 10.3390/ijms20102530. Int J Mol Sci. 2019. PMID: 31126017 Free PMC article. Review.

2

Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma.

Di Rocco A, Camero S, Benedetti A, Lozanoska-Ochser B, Megiorni F, Marchese C, Stramucci L, Ciccarelli C, Bouché M, Bossi G, Marampon F, Zani BM. Di Rocco A, et al. Among authors: ciccarelli c. Oncol Rep. 2022 Sep;48(3):151. doi: 10.3892/or.2022.8363. Epub 2022 Jul 8. Oncol Rep. 2022. PMID: 35801577 Free PMC article.

3

Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization.

Petragnano F, Pietrantoni I, Camero S, Codenotti S, Milazzo L, Vulcano F, Macioce G, Giordani I, Tini P, Cheleschi S, Gravina GL, Festuccia C, Rossetti A, Delle Monache S, Ordinelli A, Ciccarelli C, Mauro A, Barbara B, Antinozzi C, Schiavetti A, Maggio R, Di Luigi L, Polimeni A, Marchese C, Tombolini V, Fanzani A, Bernabò N, Megiorni F, Marampon F. Petragnano F, et al. Among authors: ciccarelli c. J Biomed Sci. 2020 Aug 27;27(1):90. doi: 10.1186/s12929-020-00683-6. J Biomed Sci. 2020. PMID: 32854690 Free PMC article.

4

Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay.

Marampon F, Gravina GL, Zani BM, Popov VM, Fratticci A, Cerasani M, Di Genova D, Mancini M, Ciccarelli C, Ficorella C, Di Cesare E, Festuccia C. Marampon F, et al. Among authors: ciccarelli c. Int J Oncol. 2014 Jun;44(6):2121-31. doi: 10.3892/ijo.2014.2358. Epub 2014 Mar 24. Int J Oncol. 2014. PMID: 24676782

5

Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo.

Ciccarelli C, Di Rocco A, Gravina GL, Mauro A, Festuccia C, Del Fattore A, Berardinelli P, De Felice F, Musio D, Bouché M, Tombolini V, Zani BM, Marampon F. Ciccarelli C, et al. J Cancer Res Clin Oncol. 2018 Sep;144(9):1685-1699. doi: 10.1007/s00432-018-2696-3. Epub 2018 Jun 29. J Cancer Res Clin Oncol. 2018. PMID: 29959569

6

Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis.

Marampon F, Gravina GL, Scarsella L, Festuccia C, Lovat F, Ciccarelli C, Zani BM, Polidoro L, Grassi D, Desideri G, Evangelista S, Ferri C. Marampon F, et al. Among authors: ciccarelli c. J Hypertens. 2013 Oct;31(10):1972-83. doi: 10.1097/HJH.0b013e3283638b32. J Hypertens. 2013. PMID: 23868084

7

Valproic acid affects the engraftment of TPO-expanded cord blood cells in NOD/SCID mice.

Vulcano F, Milazzo L, Ciccarelli C, Barca A, Agostini F, Altieri I, Macioce G, Di Virgilio A, Screnci M, De Felice L, Giampaolo A, Hassan HJ. Vulcano F, et al. Among authors: ciccarelli c. Exp Cell Res. 2012 Feb 15;318(4):400-7. doi: 10.1016/j.yexcr.2011.11.012. Epub 2011 Dec 6. Exp Cell Res. 2012. PMID: 22166516

8

MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma.

Marampon F, Bossi G, Ciccarelli C, Di Rocco A, Sacchi A, Pestell RG, Zani BM. Marampon F, et al. Among authors: ciccarelli c. Mol Cancer Ther. 2009 Mar;8(3):543-51. doi: 10.1158/1535-7163.MCT-08-0570. Epub 2009 Mar 3. Mol Cancer Ther. 2009. PMID: 19258428

9

Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines.

Marampon F, Di Nisio V, Pietrantoni I, Petragnano F, Fasciani I, Scicchitano BM, Ciccarelli C, Gravina GL, Festuccia C, Del Fattore A, Tombolini M, De Felice F, Musio D, Cecconi S, Tini P, Maddalo M, Codenotti S, Fanzani A, Polimeni A, Maggio R, Tombolini V. Marampon F, et al. Among authors: ciccarelli c. Cancer Lett. 2019 Oct 1;461:90-101. doi: 10.1016/j.canlet.2019.07.009. Epub 2019 Jul 17. Cancer Lett. 2019. PMID: 31325529

10

Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population.

Ciccarelli C, Vulcano F, Milazzo L, Gravina GL, Marampon F, Macioce G, Giampaolo A, Tombolini V, Di Paolo V, Hassan HJ, Zani BM. Ciccarelli C, et al. Mol Cancer. 2016 Feb 20;15:16. doi: 10.1186/s12943-016-0501-y. Mol Cancer. 2016. PMID: 26897742 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year